Previous 10 | Next 10 |
PAR Technology (NYSE: PAR ) +37% on Q1 results . More news on: PAR Technology Corporation, Penn Virginia Corporation, Camping World Holdings, Inc., Stocks on the move, , Read more ...
The FDA has signed off on Pluristem Therapeutics' (NASDAQ: PSTI ) IND for a 140-subject Phase 2 clinical trial evaluating its PLX cells in severely ill COVID-19 patients with acute respiratory distress syndrome. More news on: Pluristem Therapeutics Inc., Healthcare stocks news, Stocks on...
140 patients with severe COVID-19 and ARDS to be treated Primary endpoint: ventilator free days during the main 28-day study period, secondary endpoint includes survival rate and ICU free days HAIFA, Israel, May 08, 2020 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. ...
The SARS-CoV2 pandemic has ignited a massive effort across the globe, led by medical researchers and biotech companies, to come up with therapies that can help patients and bring an end to the pandemic. Vaccines, antibodies, immunity and convalescent plasma have all become common medical ter...
HAIFA, Israel, May 05, 2020 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading regenerative medicine company developing a platform of novel biological therapeutic products, announced today that it has entered into definitive agreements with two i...
Stemline Therapeutics (NASDAQ: STML ) +151% on Menarini bid . More news on: Stemline Therapeutics, Inc., Applied DNA Sciences, Inc., KLX Energy Services Holdings, Inc., Stocks on the move, , Read more ...
• Elaborating on agreement terms and tranches schedule • Provides update on cash position and clinical program HAIFA, Israel, April 30, 2020 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI) (the “Company”), a leading r...
HAIFA, Israel, April 30, 2020 (GLOBE NEWSWIRE) -- European Investment Bank (EIB) backs Pluristem with €50 million of financing, which will help the company to advance the clinical development of its cell therapies and address a number of severe medical conditions The ...
Gainers: Capricor Therapeutics (NASDAQ: CAPR ) +248% . More news on: Capricor Therapeutics, Inc., Chimerix, Inc., Sientra, Inc., Stocks on the move, , Read more ...
Medical professionals would surely welcome any safe and effective treatment option for people with COVID-19 -- and pharmaceutical companies are doing their best to hastily find solutions. Preclinical and clinical trials now under way are testing seemingly every plausible hypothesis, from failed ...
News, Short Squeeze, Breakout and More Instantly...
Pluristem Therapeutics Inc. Company Name:
PSTI Stock Symbol:
NASDAQ Market:
Pluristem Therapeutics Inc. Website:
HAIFA, Israel, July 25, 2022 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq: PLUR) (TASE: PLUR) (“Pluri” or the “Company”) (formerly known as Pluristem Therapeutics, Inc.), a leading biotechnology company, today issued an update to its shareholders from its Chief Executi...
As of July 26 , 2022 , Pluri ’s stock will trade under the symbol PLUR The new name reflects the Company ’s strategy to leverage its innovative 3D cell-based technology to a range of fields, developing cel...
The Company will host an analyst and investor call to discuss the phase III muscle regeneration following hip fracture surgery topline results on July 14 at 9:00 a.m. ET; for registration: https://pluristem.zoom.us/webinar/register/WN_kp_CwQQtR-aFtjAXrdiJpA HAIFA, Israel, Ju...